×







We sell 100% Genuine & New Books only!

Clinical Innovation in Rheumatology 1st Edition 2022 Hardbound at Meripustak

Clinical Innovation in Rheumatology 1st Edition 2022 Hardbound by Liebowitz, Jason, Taylor and Francis Ltd

Books from same Author: Liebowitz, Jason

Books from same Publisher: Taylor and Francis Ltd

Related Category: Author List / Publisher List


  • Price: ₹ 15414.00/- [ 13.00% off ]

    Seller Price: ₹ 13410.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Liebowitz, Jason
    PublisherTaylor and Francis Ltd
    Edition1st Edition
    ISBN9781032074924
    Pages184
    BindingHardbound
    LanguageEnglish
    Publish YearOctober 2022

    Description

    Taylor and Francis Ltd Clinical Innovation in Rheumatology 1st Edition 2022 Hardbound by Liebowitz, Jason

    Key Features* Features concise yet thorough description of the landmark studies and scientific breakthroughs coupled with easy-to-follow organizational structure of chapters that are accessible to readers at different levels of training.* Brings together world-leading experts to provide a fresh perspective to trainees such as residents and fellows-in-training, as well as more senior clinicians and researchers across the field of rheumatology and in specialties such as cardiology, dermatology, pulmonology, nephrology, and neurology, all of whom care for patients with rheumatologic conditions.* Allows the author to imagine and speculate about the evolution of this field in the coming decades. Examples of such speculative possibilities include use of synovial biopsy to predict response to treatment in rheumatoid arthritis, replacement of renal biopsy with urinary proteomics in diagnosing and classifying lupus nephritis, use of new therapeutics to obviate the need for steroids in the treatment of ANCA-associated vasculitis, use of machine learning to evaluate subtle changes in imaging in management of inflammatory arthritis, etc. Chapter 1: Rheumatoid ArthritisChapter 2: Axial SpondyloarthritisChapter 3: Psoriatic arthritisChapter 4: Crystalline ArthritisChapter 5: OsteoarthritisChapter 6: Systemic Lupus ErythematosusChapter 7: Sjogren's DiseaseChapter 8: SclerodermaChapter 9: MyositisChapter 10: VasculitisChapter 11: OsteoporosisChapter 12: Immune-related Adverse Events: A Novel Paradigm of the Immune SystemChapter 13: Complementary and Alternative Medicine Use in Rheumatic DiseaseChapter 14: COVID-19 and MIS-C



    Book Successfully Added To Your Cart